ELV Elevance Health, Inc. Common Stock
NYSE · Health Care · Visualizza su SEC EDGAR ↗ chiudi Ott 6, 2026 10-K/10-Q Lug 15, 2026ELV Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
ELV Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 01 Giugno 2005 | 2-for-1 | Avanti |
Informazioni su Elevance Health, Inc. Common Stock Panoramica della società da Wikipedia
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.
Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing (BPO)/Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States.
History
Anthem
In 1946, Anthem began in Indianapolis, Indiana, as Mutual Hospital Insurance Inc. and Mutual Medical Insurance Inc. The companies grew significantly, controlling 80% of the medical insurance market in Indiana by the 1970s.
In 1972, the two firms, then known as Blue Cross of Indiana and Blue Shield of Indiana, entered into a joint operating agreement.
In 1985, the two companies merged into Associated Insurance Companies, Inc,, later called, The Associated Group, a holding company, but usage of the name "Anthem" persisted. In 1989, the company purchased American General Insurance Co. for $150 million and in 1991, it acquired The Shelby Insurance Co., based in Shelby, Ohio, for $125 million. In 1989, The Associated Group founded Acordia, a brokerage that sold and serviced insurance and employee benefit programs.
In 1993, Acordia acquired American Business Insurance for $130 million and the Federal Kemper Insurance Company for $100 million. The Associated Group merged with Southeastern Mutual Insurance Company, the operator of Blue Cross and Blue Shield of Kentucky. In 1994, it sold Raffensperger, Hughes & Co., Inc., Indiana's largest investment bank, to National City Corp.
In 1995, The Associated Group acquired Community Mutual Insurance, a provider of Blue Cross and Blue Shield insurance plans in Ohio with over 1.9 million policy holders), then set up Anthem Blue Cross and Blue Shield. In 1996, The Associated Group changed its name to Anthem Insurance Company. In August 1997, Anthem acquired Blue Cross and Blue Shield of Connecticut. It also sold Acordia to management.
In 1999, Anthem acquired Blue Cross and Blue Shield of New Hampshire and Blue Cross and Blue Shield of Colorado and Nevada, using debt financing. The acquisitions made since 1996 added 850,000 policy holders. Among its customer base were 2.4 million PPO and 964,000 HMO enrollees.
In 2000, Anthem acquired Blue Cross Blue Shield of Maine. The Gramm-Leach-Bliley Act of 1999 made it possible for Anthem to undergo demutualization and become a public company via an initial public offering, which made it the fourth largest public managed health care company in the United States.
In 2002, Anthem acquired Trigon Healthcare of Virginia, a Blue Cross and Blue Shield plan, the largest insurer in Virginia, for $4.04 billion. Anthem Insurance Company reached 11.9 million members.
Blue Cross of California
Blue Cross of California was the predecessor of WellPoint Health Network Inc.
In 1982, Blue Cross of California was founded with the consolidation of Blue Cross of Northern California (established in 1936) and Blue Cross of Southern California (established in 1937).
In 1992, WellPoint was formed to operate Blue Cross of California's managed care business. In January 1993, Blue Cross of California spun off its managed care business into a publicly traded entity, WellPoint Health Networks Inc. Blue Cross of California retained an 80% interest and voting control.
In 1996, Blue Cross of California restructured to a for-profit corporation, designating WellPoint Health Networks Inc. as the parent organization. In April 1996, WellPoint completed its acquisition of Massachusetts Mutual Life Insurance Company's group life and health insurance subsidiaries for approximately $380 million, making it the second-largest publicly held managed health company in the U.S. with 4 million policyholders.
In March 1997, WellPoint acquired the group health and life businesses of John Hancock Financial for $86.7 million. With this acquisition, WellPoint expanded its presence into Michigan, Texas, and the mid-Atlantic, and gained a unit that concentrated on serving the needs of large employers.
In 2000, WellPoint acquired PrecisionRx, a mail service pharmacy fulfillment center in Texas. In March 2000, WellPoint acquired Rush Prudential Health Plans, a Chicago provider, for $204 million. In March 2001, WellPoint acquired Cerulean Companies, the parent company of Blue Cross Blue Shield of Georgia. In 2001, WellPoint offered to acquire CareFirst BlueCross BlueShield for $1.37 billion, including $119 million in bonuses to Carefirst executives. In 2003, the offer was rejected by the Maryland insurance commissioner.
In 2002, WellPoint acquired RightChoice Managed Care, a Missouri-based company that ran Blue Cross and Blue Shield for part of the state, for $1.5 billion. RightChoice also owned provider network company HealthLink. WellPoint also acquired MethodistCare of Houston, Texas and HealthLink. In 2003, WellPoint acquired Golden West Dental and Vision of Camarillo, California, and Cobalt, including Blue Cross and Blue Shield United of Wisconsin.
In November 2004, Wellpoint, Inc. was formed by the merger of Anthem Insurance Company and WellPoint Health Networks Inc. The merger was structured as Anthem acquiring WellPoint Health Networks and renaming itself WellPoint, Inc. WellPoint continued to use 'Anthem' as the brand name under which it operated. It sold its Blue Cross and Blue Shield products in 11 states.
In 2005, WellPoint acquired Alexandria, Virginia–based Lumenos, a provider of consumer-driven health care, for $185 million. Lumenos was the pioneer and market leader in consumer-driven health plans. In December, WellPoint acquired WellChoice, a New York City-based Blue Cross Blue Shield provider, for approximately $6.5 billion, making New York the 14th state in which WellPoint is a Blue Cross Blue Shield licensee.
In 2007, WellPoint acquired Chicago-based American Imaging Management, a radiology benefit management company that creates software to help physicians choose cost-effective locations for their patients to receive medical imaging tests. WellPoint also acquired Chicago-based American Imaging Management (AIM), the leading radiology benefit management company.
In January 2008, Leslie Margolin became the president of California operations. She resigned in July 2010. In 2008, WellPoint acquired Resolution Health, a firm that analyzes patient history for potential medical problems such as adverse drug interactions. In 2009, WellPoint acquired DeCare Dental, a dental insurance firm.
In 2011, WellPoint acquired CareMore, a Cerritos, California-based provider of insurance and care centers for elderly patients. In 2012, WellPoint acquired Amerigroup for $4.9 billion, anticipating significant growth due to Medicaid expansion under the Patient Protection and Affordable Care Act. In August 2012, CEO Angela Braly resigned due to pressure from investors.
On August 13, 2014, WellPoint announced it intended to change its name to Anthem, Inc., effective in December.
Anthem, Inc.
In February 2015, the company acquired Simply Healthcare Holdings, a Medicaid and Medicare managed care company based in Florida. In June 2015, Anthem made an offer to acquire Cigna for more than $54 billion in cash and stock. In February 2017, United States district court Judge Amy Berman Jackson blocked the Cigna merger on grounds of anti-competitive practices. On February 14, Cigna called off its merger agreement with Anthem.
In October 2017, Anthem announced that it would not renew its pharmacy benefit management (PBM) relationship with Express Scripts saying it had been overcharged $3 billion and that instead, Anthem would eventually handle the PBM process itself through its new IngenioRx unit. Anthem announced that it would enter a 5-year contract with CVS Health. Cigna then announced plans in March 2018 to acquire Express Scripts for $58 billion. On November 6, 2017, Gail Koziara Boudreaux was named CEO. In 2018, the company announced a $20 million expansion of its headquarters and the signing of a lease in Atlanta for its technology center. In March 2020, Anthem announced the acquisition of Beacon Health Options, and independently held behavioral health organization.
On February 2, 2021, Anthem announced the acquisition of InnovaCare Health's Puerto Rico subsidiaries including MMM Holdings, LLC ("MMM") and its Medicare Advantage (MA) plan MMM Healthcare, LLC as well as affiliated companies and Medicaid plan. In November 2021, Anthem announced the acquisition of Integra Managed Care in New York. The acquisition of the New York-based international health insurance company was completed on May 5, 2022.
On June 28, 2022, Anthem announced a change of its corporate name to Elevance Health, Inc. and also changed its stock ticker symbol from "ANTM" to "ELV".
Elevance Health
On January 23, 2023, Elevance announced that it entered a definitive agreement to acquire Blue Cross and Blue Shield of Louisiana, increasing Elevance's footprint to 15 states and adding 1.9 million new members. In 2023, Elevance announced that it would rebrand its Amerigroup business as Wellpoint starting in 2024.
As of 2025, Elevance subsidiaries Carelon Behavioral Health and Anthem Blue Cross and Blue Shield are the subject of three lawsuits in New York and Connecticut alleging that they operate ghost networks.
Subsidiaries
Elevance Health includes the following subsidiaries:
Amerigroup
District of Columbia (Medicaid)
Georgia (Medicaid)
New Mexico (Medicare Advantage)
Anthem Blue Cross
California
Blue Cross of California Partnership Plan (Medicaid)
New York (upstate)
Anthem Blue Cross Blue Shield
Colorado
Connecticut
Georgia
Indiana (includes Medicaid)
Kentucky
Anthem Blue Cross and Blue Shield Medicaid
Maine
Missouri (excluding 30 counties in the Kansas City area)
Nevada
Anthem Blue Cross and Blue Shield Healthcare Solutions (Medicaid)
New Hampshire
New York (downstate)
HealthPlus (Medicaid)
Ohio
Virginia (excluding Alexandria City, Arlington County, Falls Church City, and parts of Fairfax County)
HealthKeepers (Medicaid)
Wisconsin
Carelon Behavioral Health
Carelon Behavioral Health of California
Carelon Behavioral Health of Kansas
Carelon Health of Pennsylvania
Carelon Global Solutions (Business Process Outsourcing/Shared Services)
Freedom Health
Florida
Golden West Dental & Vision
California
HealthSun
Florida
MMM
Puerto Rico
Optimum Healthcare
Florida
Simply Healthcare
Florida
UniCare
West Virginia
WellPoint
Arizona (Medicare Advantage)
Iowa (Medicaid and Medicare Advantage)
Maryland (Medicaid)
Massachusetts (government employees)
New Jersey (Medicaid and Medicare Advantage)
Tennessee (Medicaid and Medicare Advantage)
Texas (Medicaid and Medicare Advantage)
Washington (Medicaid and Medicare Advantage)
Joint ventures
Elevance Health operates joint ventures including:
Anthem | MaineHealth (with MaineHealth)
Maine
Blue Medicare Advantage (with Independence Blue Cross)
Pennsylvania
Colorado Community Health Alliance (with Centura Health, Physician Health Partners and Primary Physician Partners)
Colorado
Healthy Blue Kansas (with Blue Cross and Blue Shield of Kansas and Blue Cross and Blue Shield of Kansas City)
Kansas
Healthy Blue Louisiana (with Blue Cross Blue Shield of Louisiana)
Louisiana
Summit Community Care
Arkansas
Centers Plan for Healthy Living
New York, Florida
Quality of care
In 2011, in the category of "Meeting National Standards of Care," California's state patient advocacy office gave Anthem a rating of 2 out of 4 stars. In 2014, it received 3 out of 4 stars in the same category. In 2022, twenty-one of Elevance Health's affiliated Medicaid plans earned accreditation for health equity from the National Committee for Quality Assurance (NCQA).
Controversies
Charitable donations
In 2007, WellPoint pledged to spend $30 million over three years, through the company's charitable foundation, to help the uninsured. In March 2010, the Los Angeles Times reported that WellPoint's tax records and website showed that the company had given only $6.2 million by 2009. The company said that the foundation had indeed fulfilled its $30-million commitment by mid-2009, but refused to provide any financial details to support its claim.
2007 DMHC investigation
In 2007, the California Department of Managed Health Care (DMHC) investigated Anthem's policies for revoking (rescinding) health care insurance policies. The DMHC randomly selected 90 instances where Anthem canceled the insurance of policy holders who had been diagnosed with costly or life-threatening illnesses, to find how many of these cancellations were legal. The agency concluded that all these cancellations were illegal.
In July 2008, Anthem Blue Cross agreed to a settlement with the California Department of Managed Health Care; however in doing so, WellPoint did not officially admit liability. To resolve allegations of improper policy rescissions (cancellations), WellPoint paid $10 million and reinstated plans for 1,770 policy-holders who were affected by cancelled policies. The company also agreed to provide compensation for any medical debts incurred by these policy-holders.
2010 Reuters exposé
In April 2010, Reuters alleged that Wellpoint "using a computer algorithm, identified women recently diagnosed with breast cancer and then singled them out for cancellation of their policies." The software used immediately triggered fraud investigation for those recently diagnosed with the disease as the company searched for some pretext to drop their policies. Wellpoint argued that its algorithm was scanning for diagnostic codes for conditions that patients might have known about during the insurance application. The story not only caused considerable public outrage, but it also led Secretary of Health and Human Services, Kathleen Sebelius, and President Barack Obama, to call on WellPoint to end the practice.
In 2011, Anthem began cancelling policies of members who had been paying premiums with credit cards, sometimes without calling or emailing the member ahead of time.
Opposition to healthcare reform
In August 2009, Anthem, the largest for-profit insurer in California, contacted its employees and urged them to get involved to oppose healthcare reforms proposed during the Obama administration. Consumer Watchdog, a nonprofit watchdog organization in Santa Monica, asked California Attorney General Jerry Brown to investigate its claim that WellPoint had illegally pushed workers to write to their elected officials, attend town hall meetings and enlist family and friends to ensure an overhaul that would match the firm's interests. According to Consumer Watchdog, California's labor code directly prohibits coercive communications, including forbidding employers from controlling, coercing or influencing employees' political activities or affiliations. WellPoint had not been contacted by the California attorney general and had not seen any complaint.
Through 2010 and into 2011, WellPoint senior executives met monthly with executives of other major health insurers to blunt the effect of the Patient Protection and Affordable Care Act.
Premium increases in Maine
In 2009, Anthem Health Plans of Maine, a WellPoint subsidiary, sued the state of Maine for the right to increase premiums further. Since Maine licenses insurance companies through its Bureau of Insurance, Anthem needed the state's permission to raise rates. The Court disagreed with Anthem and found that, unlike with other forms of insurance, the Maine Insurance Code does not require the Superintendent to consider profits.
Rate increases in California
In February 2010, WellPoint announced that rates would increase on some Anthem Blue Cross individual policies in California by as high as 39%. The announcement resulted in an investigation by regulators from the Federal and California governments. Anthem Blue Cross gained worldwide media attention and became a poster child for the problem of rising cost of health care in the U.S. The rate increase came one year after Anthem had raised rates 68% on individual policy holders.
To explain the rate increases, some which were four times the rate of medical inflation, Anthem said the company had experienced a death spiral: the company claimed that with increased unemployment and declining wages, healthy customers dropped their insurance policies. Consequently, the remaining risk pool became sicker and thus more expensive to insure; and, in turn, prices were forced up and pushed more people out of the market.
In response to the outrage from politicians and consumers, Anthem postponed the rate increase until May 1, 2010.
Senator Dianne Feinstein of California proposed giving the Federal government of the United States authority to block insurance premium hikes that it considers to be "unjustified".
WellPoint cost reclassification
On March 17, 2010, WellPoint announced it was reclassifying some of its administrative costs as medical care costs in order to meet loss ratio requirements under the Patient Protection and Affordable Care Act, which requires insurers to spend at least 80% or 85% of customer premiums on health care services, depending on the type of plan.
2009–2010 data breach
In June 2010, Anthem sent letters to 230,000 customers in California warning them that their personal data might have been accessed online via a data breach. After a routine upgrade in October 2009, a third-party vendor stated that all security measures had been properly reinstated, when in fact they had not. As a result, personal information of thousands of coverage applicants who were under the age of 65 was exposed in the open. After a Los Angeles-area woman found that her application for coverage was publicly available, she filed a class action lawsuit against Anthem. While gathering evidence for the proceeding, the woman's lawyers downloaded some confidential customer information from Anthem's website and alerted Anthem about the breach. According to the lawyers, confidential information had remained exposed for five months. Greg Zoeller, Indiana's Attorney General, filed a lawsuit against the company seeking $300,000 in civil penalties for the company alleged failure to notify its consumers about the breach.
Denial of benefits for cancer treatment
In May 2014, Anthem Blue Cross refused to pay for the hospitalization of a Sonoma County, California man for stage four cancers, although he had paid Anthem over $100,000 in premiums. Anthem ended up paying for coverage following public outcry.
2015 data breach
On February 4, 2015, Anthem, Inc. disclosed that criminal hackers had broken into its servers and potentially stolen over 37.5 million records that contain personally identifiable information from its servers. According to Anthem, Inc., the data breach extended into multiple brands Anthem, Inc. uses to market its healthcare plans, including, Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia, Empire Blue Cross and Blue Shield, Amerigroup, Caremore, and UniCare. Healthlink was also victimized. Anthem says the medical information and financial data was not compromised. Anthem has offered free credit monitoring in the wake of the breach. According to Bloomberg News, China may be responsible for this data breach. Michael Daniel, chief adviser on cybersecurity for President Barack Obama, said he would be changing his own password. About 80 million company records were hacked, stoking fears that the stolen data could be used for identity theft. The compromised information contained names, birthdays, medical IDs, social security numbers, street addresses, e-mail addresses, employment information and income data. In June 2017, Anthem agreed to spend $115M to settle allegations that it failed to adequately protect the data of its clients, the sum was to be spent on two years of services to protect victims from identity theft. In 2019, two Chinese nationals were indicted for the breach.
"Avoidable ER program"
Beginning in 2015, Anthem has been implementing and expanding its "avoidable ER program" which means not reimbursing ER visits when the cause is not covered by the company. A few patients found out that they had been stuck with bills of over $10,000 that Anthem refused to reimburse. According to a 2013 report by the Journal of the American Medical Association, 87 percent of patients initially triaged as non-urgent ended up with a diagnosis that constituted an emergency. Critics derided the scheme, citing that it was unlawful by federal law to cover a person based on diagnosis, not symptoms. It was also considered unsafe, as it pressured patients to diagnose themselves before going to the ER.
Neglecting complaints
In 2017, the California Department of Managed Health Care fined the company $5 million for untimely response to consumer complaints. In 2019, this was settled at $2.8 million.
2019 lawsuit for coercive direct payments
In 2019, Sovereign Health pressed charges against Anthem, alleging that it was using direct payments to compel them to join Anthem's network under unfavorable terms. Sovereign owns facilities that treat people with addiction and mental health problems.
Diagnostics fraud
In March 2020, Anthem was sued by the Department of Justice. The lawsuit alleges that Anthem had submitted inaccurate diagnostics data in order to obtain increased Medicare reimbursements. In October 2022, a judge ordered Anthem to face the lawsuit.
Medicare Advantage star rating
In January 2024, Elevance Health filed a lawsuit with the Department of Health and Human Services (HHS) challenging changes in the Medicare Advantage star rating methodology. Star ratings are tied to key bonus payouts, and due to the new rating system in 2024 ratings have significantly decreased.
Finances
For the fiscal year 2017, Anthem reported earnings of US$3.843 billion, with an annual revenue of US$90.039 billion, an increase of 6.1% over the previous fiscal cycle. Anthem's shares traded at over $183 per share, and its market capitalization was valued at over US$69.1 billion in October 2018.
Recognition
The company was featured on the S&P Dow Jones Sustainability Index from 2018 to 2022, was named by Fortune as one of the 100 Best Companies to Work For, and was included on the Corporate Equality Index's list of Best Places to Work for LGBTQ Equality from 2015 to 2022.
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | ELV | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | 17.5media 5 anni ≈17.3 | ≈17.3 | 36.3 | Sottovalutato | |
| P/S (TTM) | 0.4media 5 anni ≈0.6 | ≈0.6 | 0.7 | Sottovalutato | |
| P/B (MRQ) | 1.9media 5 anni ≈2.6 | ≈2.6 | 3.9 | Sottovalutato | |
| EV / EBITDA | 12.6media 5 anni ≈12.8 | ≈12.8 | 16.1 | Sottovalutato | |
| Prezzo / FCF (TTM) | 13.6media 5 anni ≈18.3 | ≈18.3 | · | · | |
| Prezzo / Flusso di cassa (TTM) | 11.5media 5 anni ≈14.8 | ≈14.8 | 15.6 | Sopravvalutato | |
| EV / Revenue (EV / Ricavi) | 0.6media 5 anni ≈0.7 | ≈0.7 | · | · | |
| EV / FCF | 34.6media 5 anni ≈22.2 | ≈22.2 | · | · | |
| Prezzo / Valore contabile tangibile (MRQ) | 2.5media 5 anni ≈61.0 | ≈61.0 | · | · | |
| PEG Ratio | ≈2.5 | · | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | ELV | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine Operativo (TTM) | 2.7%media 5 anni ≈4.8% | ≈4.8% | 3.5% | In linea | |
| Margine EBITDA (TTM) | 3.5%media 5 anni ≈5.7% | ≈5.7% | 3.7% | Debole | |
| Margine ante imposte (TTM) | 2.9%media 5 anni ≈4.6% | ≈4.6% | 2.8% | Di prim'ordine | |
| Margine di Profitto Netto (TTM) | 2.5%media 5 anni ≈3.6% | ≈3.6% | 2.9% | In linea | |
| ROA (TTM) | 4.0%media 5 anni ≈5.7% | ≈5.7% | 3.0% | Di prim'ordine | |
| ROE (TTM) | 11.2%media 5 anni ≈15.5% | ≈15.5% | 10.1% | Di prim'ordine | |
| ROIC | 8.0%media 5 anni ≈9.4% | ≈9.4% | 8.0% | In linea |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | ELV | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto (MRQ) | 0.7media 5 anni ≈0.7 | ≈0.7 | 0.7 | In linea | |
| Rapporto corrente (MRQ) | 1.5media 5 anni ≈1.5 | ≈1.5 | 1.7 | Bassa liquidità | |
| Quick Ratio | 0.2media 5 anni ≈0.2 | ≈0.2 | 1.3 | Bassa liquidità | |
| Debito a lungo termine / Patrimonio netto (MRQ) | 0.7media 5 anni ≈0.6 | ≈0.6 | 0.7 | In linea |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | ELV | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 12.5%media 5 anni ≈10.4% | ≈10.4% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | 8.3%media 5 anni ≈9.6% | ≈9.6% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | 10.3% | · | · | · | |
| EPS YoY | -1.8%media 5 anni ≈8.0% | ≈8.0% | · | · | |
| Net Income YoY (Utile Netto YoY) | -5.3%media 5 anni ≈5.3% | ≈5.3% | · | · | |
| EPS CAGR 3Y (CAGR EPS 3 anni) | 1.3%media 5 anni ≈4.7% | ≈4.7% | · | · | |
| EPS CAGR 5Y (CAGR EPS 5 anni) | 7.0% | · | · | · | |
| Net Income CAGR 3Y (CAGR Utile Netto 3 anni) | -1.3%media 5 anni ≈2.4% | ≈2.4% | · | · | |
| Net Income CAGR 5Y (CAGR Utile Netto 5 anni) | 4.4% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | ELV | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 1.7media 5 anni ≈1.6 | ≈1.6 | 2.4 | Debole | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$2.1M | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y
| Data ex-dividendo | Importo | Valuta | Rendimento |
|---|---|---|---|
| Set 10, 2026 | $1,72 | USD | ≈1.6% |
| Giu 10, 2026 | $1,72 | USD | ≈1.7% |
| Mar 10, 2026 | $1,72 | USD | ≈2.4% |
| Dic 5, 2025 | $1,71 | USD | ≈2.1% |
| Set 10, 2025 | $1,71 | USD | ≈2.2% |
| Giu 10, 2025 | $1,71 | USD | ≈1.7% |
| Mar 10, 2025 | $1,71 | USD | ≈1.6% |
| Dic 5, 2024 | $1,63 | USD | ≈1.7% |
| Set 10, 2024 | $1,63 | USD | ≈1.2% |
| Giu 10, 2024 | $1,63 | USD | ≈1.2% |
| Mar 7, 2024 | $1,63 | USD | ≈1.2% |
| Dic 5, 2023 | $1,48 | USD | ≈1.2% |
| Set 7, 2023 | $1,48 | USD | ≈1.3% |
| Giu 8, 2023 | $1,48 | USD | ≈1.2% |
| Mar 9, 2023 | $1,48 | USD | ≈1.2% |
| Dic 2, 2022 | $1,28 | USD | ≈0.98% |
| Set 8, 2022 | $1,28 | USD | ≈1.0% |
| Giu 9, 2022 | $1,28 | USD | ≈0.99% |
| Mar 9, 2022 | $1,28 | USD | ≈1.0% |
| Dic 2, 2021 | $1,13 | USD | ≈1.1% |
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Lug 15, 2026 | $7.45 | $6.27 | 18.9% |
| 31 Marzo 2026 | $12.58 | $10.93 | 15.1% | |
| 31 Dicembre 2025 | $3.33 | $3.13 | 6.5% | |
| 30 Settembre 2025 | $6.03 | $4.98 | 21.0% | |
| 30 Giugno 2025 | $8.84 | $9.04 | -2.3% | |
| 31 Marzo 2025 | $11.97 | $11.50 | 4.1% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $199.12B | $177.01B | $171.34B | $156.59B | $138.64B | $121.87B | $104.21B | $92.11B | $90.04B | $84.86B | $79.16B | $73.87B | |
| Cost of Revenue | $21.18B | $19.75B | $17.29B | $13.04B | $10.89B | $8.95B | $1.99B | $0 | $0 | · | · | · | |
| SG&A Expense | $20.98B | $20.02B | $20.09B | $17.70B | $15.92B | $17.45B | $13.36B | $14.02B | $12.65B | $12.56B | $12.53B | $11.75B | |
| Operating Income | $7.20B | $7.86B | $8.50B | $8.28B | $7.56B | $6.36B | $6.00B | $5.43B | $4.17B | $4.80B | $4.75B | $4.42B | |
| Interest Expense | · | · | $1.03B | $851M | $798M | $784M | $746M | $753M | $739M | $723M | $653M | $601M | |
| Pretax Income | $6.71B | $7.90B | $7.71B | $7.60B | $8.00B | $6.24B | $5.99B | $5.07B | $3.96B | $4.55B | $4.63B | $4.37B | |
| Income Tax | $1.05B | $1.93B | $1.72B | $1.71B | $1.85B | $1.67B | $1.18B | $1.32B | $121M | $2.08B | $2.07B | $1.81B | |
| Net Income | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B | $4.57B | $4.81B | $3.75B | $3.84B | $2.47B | $2.56B | $2.57B | |
| EPS (Basic) | $25.28 | $25.81 | $25.38 | $24.56 | $25.26 | $18.23 | $18.81 | $14.53 | $14.70 | $9.39 | $9.73 | $9.31 | |
| EPS (Diluted) | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 | $17.98 | $18.47 | $14.19 | $14.35 | $9.21 | $9.38 | $8.99 | |
| Shares (Basic) | 224,000,000 | 231,700,000 | 235,900,000 | 240,000,000 | 243,800,000 | 250,800,000 | 255,500,000 | 258,100,000 | 261,500,000 | 262,900,000 | 263,000,000 | 275,900,000 | |
| Shares (Diluted) | 224,600,000 | 232,900,000 | 237,400,000 | 242,800,000 | 246,800,000 | 254,300,000 | 260,300,000 | 264,200,000 | 267,800,000 | 268,100,000 | 272,900,000 | 285,900,000 | |
| EBITDA | $8.74B | $9.26B | $10.24B | $10.13B | $8.79B | $7.51B | $6.00B | $5.43B | $4.18B | $4.80B | $4.75B | $4.42B |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9.49B | $8.29B | $6.53B | $7.39B | $4.88B | $5.74B | $4.94B | $3.93B | $3.61B | $4.08B | $2.11B | $2.15B | |
| Other Current Assets | $5.34B | $4.70B | $5.79B | $5.28B | $4.65B | $4.06B | $3.02B | $2.10B | $2.25B | $1.78B | $1.56B | $1.47B | |
| Current Assets | $63.00B | $58.94B | $60.03B | $55.62B | $51.12B | $45.75B | $39.03B | $34.32B | $36.26B | $34.31B | $30.86B | $31.95B | |
| PP&E (Net) | $4.68B | $4.65B | $4.36B | $4.32B | $3.92B | $3.48B | $3.13B | $2.73B | $2.17B | $1.98B | $2.02B | $1.94B | |
| PP&E (Gross) | $8.73B | $8.33B | $7.90B | $7.12B | $8.26B | $7.33B | $6.48B | $5.55B | $4.37B | $4.14B | $4.06B | $3.76B | |
| Accum. Depreciation | $4.06B | $3.68B | $3.54B | $2.80B | $4.34B | $3.84B | $3.35B | $2.81B | $2.20B | $2.16B | $2.04B | $1.82B | |
| Goodwill | $28.34B | $28.28B | $25.32B | $24.38B | $24.23B | $21.69B | $20.50B | $20.50B | $19.23B | $17.56B | $17.56B | $17.08B | |
| Intangibles | $11.20B | $12.09B | $10.27B | $10.31B | $10.62B | $9.40B | $8.67B | $9.01B | $8.37B | $7.96B | $8.16B | $7.96B | |
| Other Non-current Assets | $2.31B | $2.14B | $1.97B | $1.69B | $1.72B | $1.44B | $1.35B | $758M | $565M | $468M | $485M | $512M | |
| Total Assets | $121.49B | $116.89B | $108.93B | $102.75B | $97.46B | $86.61B | $77.45B | $71.57B | $70.54B | $65.08B | $61.72B | $61.68B | |
| Accounts Payable | $7.32B | $6.93B | $6.91B | $5.61B | $4.97B | $5.49B | $4.20B | $4.96B | $5.02B | $4.01B | $3.32B | $3.65B | |
| Short-term Debt | $150M | $365M | $225M | $265M | $275M | $0 | $700M | $1.15B | $1.27B | $440M | $540M | $400M | |
| Current Liabilities | $41.03B | $40.58B | $41.79B | $39.70B | $34.88B | $29.45B | $23.53B | $21.96B | $23.36B | $21.29B | $19.09B | $18.75B | |
| Capital Leases | $529M | $658M | $685M | $751M | $864M | · | · | · | · | · | · | · | |
| Deferred Tax | $2.11B | $2.15B | $1.97B | $2.02B | $2.81B | $2.02B | $2.23B | $1.96B | $1.73B | $2.78B | $2.63B | $2.95B | |
| Other Non-current Liabilities | $3.53B | $3.33B | $1.74B | $1.56B | $1.68B | $1.81B | $1.42B | $1.18B | $925M | $884M | $994M | $1.04B | |
| Total Liabilities | $77.47B | $75.46B | $69.52B | $66.42B | $61.29B | $53.42B | $45.73B | $43.03B | $44.04B | $39.98B | $38.67B | $37.42B | |
| Long-term Debt | $31.90B | $30.87B | $24.89B | $23.85B | $22.76B | $20.04B | $19.39B | $18.07B | $18.66B | $15.29B | $15.32B | $14.64B | |
| Total Debt | $32.05B | $31.23B | $25.12B | $24.11B | $23.03B | $20.04B | $20.09B | $19.21B | $19.93B | $15.73B | $15.86B | $15.15B | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Paid-in Capital | $8.94B | $8.91B | $8.87B | $9.08B | $9.15B | $9.24B | $9.45B | $9.54B | $8.55B | $8.81B | $8.56B | $10.06B | |
| Retained Earnings | $35.39B | $33.55B | $31.75B | $29.65B | $27.14B | $23.80B | $22.57B | $19.99B | $18.05B | $16.56B | $14.78B | $14.01B | |
| AOCI | $-451M | $-1.15B | $-1.31B | $-2.49B | $-197M | $150M | $-296M | $-986M | $-101M | $-268M | $-293M | $172M | |
| Stockholders' Equity | $43.88B | $41.31B | $39.31B | $36.24B | $36.09B | $33.20B | $31.73B | $28.54B | $26.50B | $25.10B | $23.05B | $24.25B | |
| Liabilities + Equity | $121.49B | $116.89B | $108.93B | $102.75B | $97.46B | $86.61B | $77.45B | $71.57B | $70.54B | $65.08B | $61.72B | $61.68B | |
| Shares Outstanding | 220,723,898 | 227,479,695 | 233,071,088 | 237,958,067 | 241,770,746 | 245,401,430 | 252,922,161 | 257,395,577 | 256,084,913 | 263,747,395 | 261,238,188 | 268,109,932 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.55B | $1.39B | $1.75B | $1.68B | $1.30B | $1.15B | $1.13B | $1.13B | · | · | · | · | |
| Stock-based Comp | $276M | $191M | $289M | $264M | $255M | $283M | $294M | $226M | $170M | $165M | $148M | $169M | |
| Deferred Tax | $-279M | $-374M | $-602M | $-115M | $342M | $-540M | $81M | $91M | $-1.27B | $127M | $-66M | $31M | |
| Amort. of Intangibles | $628M | $580M | $885M | $767M | $441M | $361M | $338M | $358M | $169M | $192M | $230M | $221M | |
| Other Non-cash | $-2.92B | $-1.38B | $642M | $511M | $377M | $5.22B | · | · | · | · | · | · | |
| Operating Cash Flow | $4.29B | $5.81B | $8.06B | $8.40B | $8.36B | $10.69B | $6.06B | $3.83B | $4.18B | $3.27B | $4.21B | $3.37B | |
| CapEx | $1.12B | $1.26B | $1.30B | $1.15B | $1.09B | $1.02B | $1.08B | $1.21B | $791M | $584M | $638M | $715M | |
| Investing Cash Flow | $-1.34B | $-5.17B | $-5.57B | $-4.56B | $-9.64B | $-7.32B | $-2.79B | $-1.26B | $-5.08B | $-514M | $-1.15B | $-975M | |
| Debt Issued | $2.99B | $7.71B | $2.57B | $3.07B | $3.46B | $2.48B | $2.47B | $835M | $5.46B | $0 | $1.23B | $2.70B | |
| Net Debt Issued | $844M | $6.06B | $665M | $1.17B | $2.39B | $552M | $1.35B | $-849M | $2.64B | $0 | $-1.47B | $970M | |
| Stock Issued | · | · | · | · | · | $0 | $0 | $1.25B | $0 | $0 | · | · | |
| Stock Repurchased | $2.60B | $2.90B | $2.68B | $2.32B | $1.90B | $2.70B | $1.70B | $1.69B | $2.00B | $0 | $1.52B | $3.00B | |
| Net Stock Activity | $-2.60B | $-2.90B | $-2.68B | $-2.32B | $-1.90B | $-2.70B | $-1.70B | $-435M | $-2.00B | $0 | $-1.52B | $-3.00B | |
| Dividends Paid | $1.53B | $1.51B | $1.40B | $1.23B | $1.10B | $954M | $818M | $776M | $705M | $684M | $657M | $481M | |
| Financing Cash Flow | $-1.74B | $1.19B | $-3.35B | $-1.32B | $423M | $-2.57B | $-2.27B | $-2.24B | $427M | $-799M | $-3.09B | $-1.82B | |
| Net Change in Cash | $1.20B | $1.83B | $-861M | $2.51B | $-861M | $804M | $1.00B | $325M | $-466M | $1.96B | $-38M | $565M | |
| Free Cash Flow | $3.17B | $4.55B | $6.76B | $7.25B | $7.28B | $9.67B | $4.98B | $2.62B | $3.39B | $2.62B | $3.48B | $2.65B | |
| Levered FCF | · | · | $5.97B | $6.59B | $6.66B | $9.09B | $4.38B | $2.06B | $2.67B | $2.23B | $3.12B | $2.30B |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.6% | 4.4% | 5.0% | 5.4% | 5.4% | 5.2% | 5.8% | 5.9% | 4.6% | 5.7% | 6.0% | 6.0% | |
| Net Margin | 2.8% | 3.4% | 3.5% | 3.9% | 4.4% | 3.8% | 4.6% | 4.1% | 4.3% | 2.9% | 3.2% | 3.5% | |
| Pretax Margin | 3.4% | 4.5% | 4.5% | 5.0% | 5.7% | 5.1% | 5.7% | 5.5% | 4.4% | 5.4% | 5.9% | 5.9% | |
| EBITDA Margin | 4.4% | 5.2% | 6.0% | 6.5% | 6.3% | 6.2% | 5.8% | 5.9% | 4.6% | 5.7% | 6.0% | 6.0% | |
| ROA | 4.8% | 5.3% | 5.7% | 6.0% | 6.6% | 5.6% | 6.5% | 5.3% | 5.7% | 3.9% | 4.2% | 4.2% | |
| ROE | 13.3% | 14.8% | 15.8% | 16.7% | 17.0% | 13.6% | 15.2% | 13.0% | 14.6% | 9.9% | 11.1% | 10.6% | |
| ROIC | 8.0% | 8.2% | 10.2% | 10.8% | 9.8% | 8.8% | 9.3% | 8.4% | 8.7% | 6.4% | 6.8% | 6.6% |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.5 | 1.4 | 1.4 | 1.5 | 1.6 | 1.7 | 1.6 | 1.6 | 1.6 | 1.6 | 1.7 | |
| Quick Ratio | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | |
| Debt / Equity | 0.7 | 0.8 | 0.6 | 0.7 | 0.6 | 0.6 | 0.6 | 0.7 | 0.8 | 0.6 | 0.7 | 0.6 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.6 | 0.7 | 0.6 | |
| Interest Coverage | · | · | 8.3 | 9.9 | 9.4 | 8.1 | 8.0 | 7.2 | 5.7 | 6.6 | 7.3 | 7.4 |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.7 | 1.6 | 1.6 | 1.6 | 1.5 | 1.5 | 1.4 | 1.3 | 1.3 | 1.3 | 1.3 | 1.2 |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $198.81 | $181.62 | $168.64 | $152.58 | $149.15 | $135.28 | $125.45 | $110.88 | $103.49 | $95.17 | $88.21 | $90.45 | |
| Revenue / Share | $886.58 | $760.03 | $721.74 | $644.95 | $561.75 | $479.23 | $400.36 | $348.62 | $336.22 | $316.53 | $290.06 | $258.39 | |
| Cash Flow / Share | $19.10 | $24.94 | $33.96 | $34.59 | $33.89 | $42.03 | $23.28 | $14.49 | $15.63 | $11.95 | $15.08 | $11.78 | |
| Cash / Share | $43.00 | $36.43 | $28.00 | $31.04 | $20.18 | $23.39 | $19.52 | $15.28 | $14.09 | $15.45 | $8.09 | $8.03 | |
| Dividend / Share | · | · | $5.92 | $5.12 | $4.52 | $3.80 | $3.20 | $3.00 | $2.70 | $2.60 | $2.50 | $1.75 | |
| EPS (TTM) | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 | $17.98 | $18.47 | $14.19 | $14.35 | $9.21 | $9.38 | $8.99 |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 12.5% | 3.3% | 9.4% | 13.0% | 13.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 8.3% | 8.5% | 12.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.8% | 1.8% | 3.9% | -2.7% | 38.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 1.3% | 0.97% | 11.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 7.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -5.3% | -0.12% | 1.6% | -4.3% | 34.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -1.3% | -0.97% | 9.4% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 4.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 9.9% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $199.12B | $177.01B | $171.34B | $156.59B | $138.64B | $121.87B | $104.21B | $92.11B | $90.04B | $84.86B | $79.16B | $73.87B | |
| Net Income TTM | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B | $4.57B | $4.81B | $3.75B | $3.84B | $2.47B | $2.56B | $2.57B | |
| Market Cap | $77.37B | $83.92B | $109.91B | $122.07B | $112.07B | $78.80B | $76.39B | $67.60B | $57.62B | $37.92B | $36.43B | $33.69B | |
| Enterprise Value | $99.93B | $106.86B | $128.50B | $138.79B | $130.22B | $93.09B | $91.54B | $82.88B | $73.94B | $49.57B | $50.18B | $46.69B | |
| P/E | 13.9 | 14.4 | 18.7 | 21.1 | 18.6 | 17.9 | 16.4 | 18.5 | 15.7 | 15.6 | 14.9 | 14.0 | |
| P/S | 0.4 | 0.5 | 0.6 | 0.8 | 0.8 | 0.6 | 0.7 | 0.7 | 0.6 | 0.4 | 0.5 | 0.5 | |
| P/B | 1.8 | 2.0 | 2.8 | 3.4 | 3.1 | 2.4 | 2.4 | 2.4 | 2.2 | 1.5 | 1.6 | 1.4 | |
| P / Tangible Book | 17.8 | 88.9 | 29.6 | 79.0 | 89.5 | 37.5 | · | · | · | · | · | · | |
| P / Cash Flow | 18.0 | 14.4 | 13.6 | 14.5 | 13.4 | 7.4 | 12.6 | 17.7 | 13.8 | 11.8 | 8.9 | 10.0 | |
| P / FCF | 24.4 | 18.4 | 16.2 | 16.8 | 15.4 | 8.2 | 15.3 | 25.8 | 17.0 | 14.5 | 10.5 | 12.7 | |
| EV / EBITDA | 11.4 | 11.5 | 12.5 | 13.7 | 14.8 | 12.4 | 15.3 | 15.3 | 17.7 | 10.3 | 10.6 | 10.6 | |
| EV / FCF | 31.5 | 23.5 | 19.0 | 19.2 | 17.9 | 9.6 | 18.4 | 31.6 | 21.8 | 18.9 | 14.4 | 17.6 | |
| EV / Revenue | 0.5 | 0.6 | 0.8 | 0.9 | 0.9 | 0.8 | 0.9 | 0.9 | 0.8 | 0.6 | 0.6 | 0.6 | |
| Dividend Yield | 2.0% | 1.8% | 1.3% | 1.0% | 0.99% | 1.2% | 1.1% | 1.1% | 1.2% | 1.8% | 1.8% | 1.4% | |
| Earnings Yield | 7.2% | 7.0% | 5.3% | 4.7% | 5.4% | 5.6% | 6.1% | 5.4% | 6.4% | 6.4% | 6.7% | 7.1% | |
| Payout Ratio | 27.0% | 25.2% | 23.3% | 20.4% | 18.1% | 20.9% | 17.0% | 20.7% | 18.3% | 27.7% | 25.7% | 18.7% | |
| Annual Payout | $1.53B | $1.51B | $1.40B | $1.23B | $1.10B | $954M | $818M | $776M | $705M | $684M | $657M | $481M |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $50.47B | $50.18B | $49.75B | $50.71B | $49.78B | $48.89B | $45.44B | $45.11B | $43.89B | $42.58B | $42.65B | $42.85B | $43.67B | $42.17B | $39.93B | $39.94B | |
| Cost of Revenue | $5.49B | $5.46B | $5.52B | $5.38B | $5.29B | $4.98B | $6.01B | $5.09B | $4.82B | $3.83B | $4.84B | $4.65B | $4.33B | $3.48B | $3.65B | $3.44B | |
| SG&A Expense | $5.55B | $6.33B | $5.42B | $5.27B | $5.00B | $5.30B | $4.80B | $5.27B | $5.07B | $4.89B | $5.00B | $5.47B | $4.82B | $4.80B | $4.57B | $4.52B | |
| Operating Income | $1.76B | $2.09B | $309M | $1.29B | $2.42B | $3.17B | $673M | $1.41B | $2.77B | $3.02B | $1.28B | $1.76B | $2.63B | $2.83B | $1.26B | $2.25B | |
| Interest Expense | · | · | · | · | · | · | · | $300M | $280M | $265M | · | $259M | $261M | $251M | · | $213M | |
| Pretax Income | $1.94B | $2.30B | $215M | $1.41B | $2.29B | $2.80B | $606M | $1.37B | $2.99B | $2.94B | $1.00B | $1.65B | $2.44B | $2.62B | $1.04B | $2.13B | |
| Income Tax | $483M | $544M | $-331M | $219M | $548M | $613M | $193M | $365M | $685M | $690M | $170M | $354M | $585M | $615M | $168M | $529M | |
| Net Income | $1.46B | $1.76B | $547M | $1.19B | $1.74B | $2.18B | $418M | $1.02B | $2.30B | $2.25B | $856M | $1.29B | $1.85B | $1.99B | $865M | $1.60B | |
| EPS (Basic) | $6.74 | $8.03 | $2.58 | $5.32 | $7.74 | $9.64 | $1.87 | $4.38 | $9.91 | $9.65 | $3.70 | $5.48 | $7.83 | $8.37 | $3.66 | $6.69 | |
| EPS (Diluted) | $6.71 | $8.00 | $2.56 | $5.32 | $7.72 | $9.61 | $1.88 | $4.36 | $9.85 | $9.59 | $3.68 | $5.45 | $7.79 | $8.30 | $3.61 | $6.62 | |
| Shares (Basic) | 217,000,000 | 219,800,000 | · | 223,300,000 | 225,200,000 | 226,400,000 | · | 231,900,000 | 232,200,000 | 232,700,000 | · | 235,300,000 | 236,600,000 | 237,500,000 | · | 239,600,000 | |
| Shares (Diluted) | 217,900,000 | 220,400,000 | · | 223,700,000 | 225,800,000 | 227,200,000 | · | 233,100,000 | 233,400,000 | 234,200,000 | · | 236,500,000 | 237,800,000 | 239,700,000 | · | 242,200,000 | |
| EBITDA | $1.76B | $2.44B | · | $1.29B | $2.42B | $3.54B | · | $1.64B | $2.77B | $3.35B | · | $1.76B | $2.63B | $3.29B | · | $2.27B |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10.23B | $9.66B | $9.49B | $8.71B | $8.56B | $7.50B | $8.29B | $7.87B | $6.50B | $6.23B | · | $10.92B | $9.99B | $10.14B | · | $8.87B | |
| Other Current Assets | $6.28B | $7.17B | $5.34B | $5.21B | $5.41B | $5.29B | $4.70B | $5.95B | $6.46B | $6.39B | · | $5.36B | $4.94B | $4.94B | · | $5.50B | |
| Current Assets | $67.18B | $67.03B | $63.00B | $63.78B | $63.32B | $61.12B | $58.94B | $62.85B | $62.27B | $60.95B | · | $61.19B | $59.74B | $59.82B | · | $55.60B | |
| PP&E (Net) | $4.64B | $4.66B | $4.68B | $4.66B | $4.64B | $4.62B | $4.65B | $4.50B | $4.45B | $4.45B | · | $4.25B | $4.55B | $4.42B | · | $4.20B | |
| PP&E (Gross) | · | · | $8.73B | · | · | · | $8.33B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $4.06B | · | · | · | $3.68B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $28.34B | $28.34B | $28.34B | $28.45B | $28.37B | $28.42B | $28.28B | $25.97B | $25.96B | $25.95B | $25.32B | $25.29B | $25.27B | $25.27B | $24.38B | $24.38B | |
| Intangibles | $10.98B | $11.09B | $11.20B | $11.33B | $11.49B | $11.94B | $12.09B | $10.32B | $10.45B | $10.71B | · | $10.49B | $10.70B | $10.91B | · | $10.54B | |
| Other Non-current Assets | $2.90B | $2.58B | $2.31B | $2.78B | $2.56B | $2.39B | $2.14B | $2.60B | $2.20B | $2.25B | · | $2.33B | $2.13B | $1.86B | · | $2.17B | |
| Total Assets | $126.44B | $125.83B | $121.49B | $122.75B | $121.94B | $119.72B | $116.89B | $116.53B | $112.99B | $111.89B | · | $110.48B | $109.17B | $109.04B | · | $103.03B | |
| Accounts Payable | $6.63B | $6.21B | $7.32B | $6.08B | $7.28B | $7.13B | $6.93B | $6.25B | $5.76B | $5.66B | · | $5.98B | $5.03B | $4.87B | · | $4.96B | |
| Short-term Debt | $0 | $724M | $150M | $180M | $360M | $250M | $365M | $360M | $225M | $1.57B | · | $0 | $265M | $265M | · | $265M | |
| Current Liabilities | $44.25B | $45.31B | $41.03B | $40.88B | $43.83B | $42.70B | $40.58B | $42.03B | $41.81B | $44.33B | · | $43.34B | $41.57B | $41.89B | · | $41.29B | |
| Capital Leases | · | · | $529M | · | · | · | $658M | · | · | · | · | $695M | $717M | $727M | · | $739M | |
| Deferred Tax | $2.21B | $1.79B | $2.11B | $2.31B | $2.01B | $2.12B | $2.15B | $2.09B | $2.04B | $2.20B | · | $1.78B | $1.85B | $2.03B | · | $1.82B | |
| Other Non-current Liabilities | $4.29B | $3.92B | $3.38B | $4.14B | $3.90B | $3.99B | $3.33B | $3.59B | $1.99B | $1.91B | · | $1.97B | $1.78B | $1.65B | · | $1.79B | |
| Total Liabilities | $81.42B | $81.78B | $77.47B | $78.67B | $78.09B | $77.10B | $75.46B | $72.65B | $70.69B | $71.18B | · | $71.94B | $70.86B | $71.58B | · | $66.98B | |
| Long-term Debt | $31.04B | $31.12B | $31.90B | $31.92B | $29.83B | $29.75B | $30.87B | $26.79B | $27.46B | $24.88B | · | $24.84B | $24.86B | $25.20B | · | $23.51B | |
| Total Debt | $31.04B | $31.84B | · | $32.10B | $30.19B | $30.00B | · | $27.15B | $27.69B | $26.45B | · | $24.84B | $25.12B | $25.47B | · | $23.77B | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Paid-in Capital | $8.92B | $8.85B | $8.94B | $8.91B | $8.93B | $8.87B | $8.91B | $9.11B | $9.00B | $8.88B | · | $8.83B | $8.76B | $8.70B | · | $9.17B | |
| Retained Earnings | $36.67B | $35.80B | $35.39B | $35.59B | $35.55B | $34.55B | $33.55B | $35.16B | $34.58B | $33.09B | · | $32.10B | $31.61B | $30.71B | · | $29.60B | |
| AOCI | $-711M | $-741M | $-451M | $-543M | $-760M | $-911M | $-1.15B | $-489M | $-1.39B | $-1.36B | · | $-2.51B | $-2.17B | $-2.05B | · | $-2.78B | |
| Stockholders' Equity | $44.88B | $43.90B | $43.88B | $43.95B | $43.72B | $42.50B | $41.31B | $43.77B | $42.19B | $40.61B | · | $38.42B | $38.20B | $37.36B | · | $35.99B | |
| Liabilities + Equity | $126.44B | $125.83B | $121.49B | $122.75B | $121.94B | $119.72B | $116.89B | $116.53B | $112.99B | $111.89B | · | $110.48B | $109.17B | $109.04B | · | $103.03B | |
| Shares Outstanding | 216,841,146 | 217,368,494 | 220,723,898 | 222,036,187 | 224,835,508 | 225,641,361 | 227,479,695 | 231,929,643 | 231,902,075 | 232,544,717 | · | 234,906,987 | 235,861,650 | 237,114,190 | · | 238,974,624 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $366M | $354M | $406M | $387M | $380M | $373M | $831M | $231M | $0 | $331M | $1.06B | $220M | $0 | $462M | $473M | $451M | |
| Stock-based Comp | $75M | $55M | $30M | $84M | $81M | $81M | $-29M | $66M | $92M | $62M | $72M | $78M | $78M | $61M | $73M | $69M | |
| Deferred Tax | $151M | $-274M | $-322M | $269M | $-52M | $-174M | $-116M | $-224M | $-170M | $136M | $-241M | $32M | $-138M | $-255M | $68M | $-11M | |
| Amort. of Intangibles | $110M | $112M | $164M | $162M | $147M | $155M | $180M | $122M | $162M | $116M | $217M | $212M | $221M | $235M | $247M | $225M | |
| Other Non-cash | · | $2.43B | · | · | · | $-1.45B | · | · | · | $-797M | · | · | · | $4.21B | · | · | |
| Operating Cash Flow | $1.91B | $4.33B | $84M | $1.14B | $2.05B | $1.02B | $706M | $2.68B | $447M | $1.98B | $-2.97B | $2.61B | $1.95B | $6.47B | $-1.52B | $4.92B | |
| CapEx | $287M | $235M | $293M | $360M | $267M | $196M | $322M | $332M | $323M | $279M | $326M | $319M | $350M | $301M | $298M | $305M | |
| Investing Cash Flow | $159M | $-1.64B | $464M | $-1.22B | $-687M | $103M | $-1.64B | $-401M | $-818M | $-2.31B | $-1.03B | $-687M | $-672M | $-3.18B | $289M | $-1.25B | |
| Debt Issued | · | · | $-3M | $2.99B | · | · | $5.13B | $0 | $2.58B | $0 | $0 | $0 | $0 | $2.57B | $1.78B | $-14M | |
| Net Debt Issued | · | $-750M | · | · | · | $-1.25B | · | · | · | $0 | · | · | · | $666M | · | · | |
| Stock Repurchased | $234M | $1.12B | $471M | $876M | $378M | $880M | $1.81B | $60M | $463M | $566M | $928M | $480M | $646M | $622M | $568M | $579M | |
| Net Stock Activity | · | $-1.12B | · | · | · | $-880M | · | · | · | $-566M | · | · | · | $-622M | · | · | |
| Dividends Paid | $373M | $376M | $377M | $376M | $385M | $386M | $373M | $386M | $378M | $379M | $346M | $348M | $350M | $351M | $305M | $306M | |
| Financing Cash Flow | $-1.49B | $-2.52B | $236M | $243M | $-308M | $-1.91B | $1.41B | $-915M | $668M | $32M | $-394M | $-994M | $-1.43B | $-531M | $-258M | $-1.25B | |
| Net Change in Cash | $575M | $166M | $778M | $153M | $1.06B | $-788M | $468M | $1.37B | $292M | $-300M | $-4.39B | $928M | $-151M | $2.75B | $-1.49B | $2.42B | |
| Free Cash Flow | · | $4.10B | · | · | · | $821M | · | · | · | $1.70B | · | · | · | $6.17B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $1.50B | · | · | · | $5.98B | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.5% | 4.2% | · | 2.5% | 4.9% | 6.5% | · | 3.1% | 6.3% | 7.1% | · | 4.1% | 6.0% | 6.7% | · | 5.7% | |
| Net Margin | 2.9% | 3.5% | · | 2.3% | 3.5% | 4.5% | · | 2.2% | 5.2% | 5.3% | · | 3.0% | 4.2% | 4.7% | · | 4.0% | |
| Pretax Margin | 3.8% | 4.6% | · | 2.8% | 4.6% | 5.7% | · | 3.0% | 6.8% | 6.9% | · | 3.9% | 5.6% | 6.2% | · | 5.4% | |
| EBITDA Margin | 3.5% | 4.9% | · | 2.5% | 4.9% | 7.2% | · | 3.6% | 6.3% | 7.9% | · | 4.1% | 6.0% | 7.8% | · | 5.7% | |
| ROA | 1.2% | 1.4% | · | 0.99% | 1.5% | 1.9% | · | 0.90% | 2.1% | 2.0% | · | 1.2% | 1.8% | 1.9% | · | 1.6% | |
| ROE | 3.3% | 4.1% | · | 2.7% | 4.1% | 5.2% | · | 2.5% | 5.7% | 5.8% | · | 3.5% | 5.0% | 5.4% | · | 4.5% | |
| ROIC | 1.7% | 2.1% | · | 1.4% | 2.5% | 3.4% | · | 1.5% | 3.0% | 3.4% | · | 2.2% | 3.2% | 3.5% | · | 2.9% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.5 | · | 1.6 | 1.4 | 1.4 | · | 1.5 | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.3 | |
| Quick Ratio | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.3 | 0.2 | 0.2 | · | 0.2 | |
| Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | |
| LT Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.7 | · | 0.6 | 0.6 | 0.5 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | |
| Interest Coverage | · | · | · | · | · | · | · | 4.7 | 9.9 | 11.4 | · | 6.8 | 10.1 | 11.3 | · | 10.7 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $206.99 | $201.97 | · | $197.95 | $194.46 | $188.37 | · | $188.74 | $181.93 | $174.62 | · | $163.57 | $161.98 | $157.54 | · | $150.61 | |
| Revenue / Share | $231.64 | $227.68 | · | $226.69 | $220.44 | $215.19 | · | $193.50 | $188.03 | $181.80 | · | $181.18 | $183.65 | $175.94 | · | $164.90 | |
| Cash Flow / Share | · | $19.66 | · | · | · | $4.48 | · | · | · | $8.45 | · | · | · | $26.99 | · | · | |
| Cash / Share | $47.19 | $44.43 | · | $39.24 | $38.07 | $33.24 | · | $33.92 | $28.02 | $26.77 | · | $46.48 | $42.36 | $42.77 | · | $37.13 | |
| Dividend / Share | $1.72 | $1.72 | · | $1.71 | $1.71 | $1.71 | · | $1.63 | $1.63 | $1.63 | · | $1.48 | $1.48 | $1.48 | · | $1.28 | |
| Dividend Paid / Share | $1.72 | $1.72 | $1.71 | $1.72 | $1.71 | $1.71 | $1.63 | $1.71 | $1.63 | $1.63 | $1.48 | $1.48 | $1.48 | $1.48 | $1.28 | $1.28 | |
| EPS (TTM) | $22.59 | $23.60 | · | $24.53 | $23.57 | $25.70 | · | $27.48 | $28.57 | $26.51 | · | $25.15 | $26.32 | $25.26 | · | $25.53 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $201.11B | $200.41B | · | $194.82B | $189.22B | $183.32B | · | $174.22B | $171.96B | $171.75B | · | $168.62B | $165.71B | $160.67B | · | $153.25B | |
| Net Income TTM | $4.96B | $5.24B | · | $5.53B | $5.36B | $5.92B | · | $6.42B | $6.69B | $6.24B | · | $6.00B | $6.31B | $6.09B | · | $6.22B | |
| Market Cap | $83.86B | $63.63B | · | $71.74B | $87.45B | $98.14B | · | $120.60B | $125.66B | $120.58B | · | $102.28B | $104.79B | $109.03B | · | $108.55B | |
| Enterprise Value | $104.67B | $85.82B | · | $95.13B | $109.08B | $120.65B | · | $139.89B | $146.85B | $140.81B | · | $116.21B | $119.92B | $124.35B | · | $123.45B | |
| P/E | 17.1 | 12.4 | · | 13.2 | 16.5 | 16.9 | · | 18.9 | 19.0 | 19.6 | · | 17.3 | 16.9 | 18.2 | · | 17.8 | |
| P/S | 0.4 | 0.3 | · | 0.4 | 0.5 | 0.5 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| P/B | 1.9 | 1.4 | · | 1.6 | 2.0 | 2.3 | · | 2.8 | 3.0 | 3.0 | · | 2.7 | 2.7 | 2.9 | · | 3.0 | |
| P / Tangible Book | 15.1 | 14.2 | · | 17.2 | 22.6 | 45.8 | · | 16.1 | 21.7 | 30.5 | · | 38.7 | 47.0 | 93.3 | · | 101.1 | |
| P / Cash Flow | · | 14.7 | · | · | · | 96.5 | · | · | · | 61.0 | · | · | · | 16.9 | · | · | |
| EV / Revenue | 0.5 | 0.4 | · | 0.5 | 0.6 | 0.7 | · | 0.8 | 0.9 | 0.8 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | |
| Dividend Yield | 1.8% | 2.4% | · | 2.1% | 1.8% | 1.6% | · | 1.2% | 1.1% | 1.2% | · | 1.3% | 1.2% | 1.2% | · | 1.1% | |
| Earnings Yield | 5.8% | 8.1% | · | 7.6% | 6.1% | 5.9% | · | 5.3% | 5.3% | 5.1% | · | 5.8% | 5.9% | 5.5% | · | 5.6% | |
| Payout Ratio | 25.5% | 21.3% | · | 32.0% | 22.1% | 17.7% | · | 37.2% | 16.4% | 16.9% | · | 27.0% | 18.9% | 17.6% | · | 18.9% | |
| Annual Payout | $1.50B | $1.51B | · | $1.52B | $1.53B | $1.52B | · | $1.49B | $1.45B | $1.42B | · | $1.35B | $1.31B | $1.27B | · | $1.20B |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $199.12B | $177.01B | $171.34B | $156.59B | $138.64B |
| Margine Operativo % | 3.6% | 4.4% | 5.0% | 5.4% | 5.4% |
| Utile netto | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B |
| EPS Diluito | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 0.7 | 0.8 | 0.6 | 0.7 | 0.6 |
| Rapporto corrente | 1.5 | 1.5 | 1.4 | 1.4 | 1.5 |
| Quick Ratio | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $3.17B | $4.55B | $6.76B | $7.25B | $7.28B |
Proprietari istituzionali (13F) 1.757 filer · $81.9B totale · Aggiornato al 30 Settembre 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 264 (+89 vs trimestre precedente) | 94 (-110 vs trimestre precedente) | 609 (+128 vs trimestre precedente) | 550 (-104 vs trimestre precedente) | +6.8M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $8.069.492.034 | 23.019.518 | 9,86% | Azioni |
| BlackRock, Inc. | $7.344.424.106 | 18.991.090 | 8,97% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $5.436.729.233 | 14.058.204 | 6,64% | Azioni |
| STATE STREET CORP | $4.032.282.885 | 10.426.610 | 4,93% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $3.563.141.883 | 9.213.513 | 4,35% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.403.277.896 | 6.214.356 | 2,94% | Azioni |
| Sanders Capital, LLC | $2.252.711.532 | 5.825.024 | 2,75% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $1.990.239.599 | 5.166.124 | 2,43% | Azioni |
| HARRIS ASSOCIATES L P | $1.904.455.957 | 4.924.511 | 2,33% | Azioni |
| Artisan Partners Limited Partnership | $1.771.695.984 | 4.581.222 | 2,16% | Azioni |
| Invesco Ltd. | $1.637.504.097 | 4.234.231 | 2,00% | Azioni |
| First Eagle Investment Management, LLC | $1.619.701.186 | 4.188.196 | 1,98% | Azioni |
| NORGES BANK | $1.531.008.381 | 3.958.856 | 1,87% | Azioni |
| Bank of New York Mellon Corp | $1.246.348.719 | 3.222.787 | 1,52% | Azioni |
| FMR LLC | $1.211.103.818 | 3.131.652 | 1,48% | Azioni |
| MORGAN STANLEY | $1.007.728.234 | 2.605.764 | 1,23% | Azioni |
| NORTHERN TRUST CORP | $817.928.536 | 2.114.986 | 1,00% | Azioni |
| CITIGROUP INC | $810.919.703 | 2.096.863 | 0,99% | Azioni |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $779.725.026 | 2.016.200 | 0,95% | Azioni |
| GOLDMAN SACHS GROUP INC | $775.630.749 | 2.005.613 | 0,95% | Azioni |
| Nuveen, LLC | $769.539.548 | 1.989.863 | 0,94% | Azioni |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $749.415.810 | 1.935.880 | 0,92% | Azioni |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $737.324.542 | 2.518.615 | 0,90% | Azioni |
| BANK OF AMERICA CORP /DE/ | $698.537.689 | 1.806.267 | 0,85% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $697.546.062 | 1.803.703 | 0,85% | Azioni |
| Legal & General Group Plc | $688.469.125 | 1.780.232 | 0,84% | Azioni |
| Grantham, Mayo, Van Otterloo & Co. LLC | $654.221.093 | 1.691.671 | 0,80% | Azioni |
| Amundi | $635.991.799 | 1.644.537 | 0,78% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $601.132.524 | 1.554.359 | 0,73% | Azioni |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $591.084.393 | 1.528.416 | 0,72% | Azioni |
| EAGLE CAPITAL MANAGEMENT LLC | $576.772.638 | 1.491.409 | 0,70% | Azioni |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $511.706.827 | 1.323.163 | 0,63% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $461.498.831 | 1.193.336 | 0,56% | Azioni |
| BAILLIE GIFFORD & CO | $418.920.245 | 1.083.237 | 0,51% | Azioni |
| JPMORGAN CHASE & CO | $386.949.330 | 997.214 | 0,47% | Azioni |
| Ruane, Cunniff & Goldfarb L.P. | $378.839.935 | 979.598 | 0,46% | Azioni |
| Brave Warrior Advisors, LLC | $377.790.736 | 976.885 | 0,46% | Azioni |
| Newport Trust Company, LLC | $369.294.278 | 954.915 | 0,45% | Azioni |
| DEUTSCHE BANK AG\ | $364.707.273 | 943.054 | 0,45% | Azioni |
| FRANKLIN RESOURCES INC | $360.834.432 | 933.040 | 0,44% | Azioni |
| 1832 Asset Management L.P. | $355.109.795 | 918.237 | 0,43% | Azioni |
| CITADEL ADVISORS LLC | $350.526.658 | 906.386 | 0,43% | Azioni |
| Capital International Investors | $290.732.899 | 751.772 | 0,36% | Azioni |
| UBS Group AG | $286.115.618 | 739.833 | 0,35% | Azioni |
| ACR Alpine Capital Research, LLC | $285.376.389 | 737.922 | 0,35% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $281.369.666 | 727.561 | 0,34% | Azioni |
| ROYAL BANK OF CANADA | $268.753.000 | 694.935 | 0,33% | Azioni |
| High Ground Investment Management LLP | $262.939.273 | 679.904 | 0,32% | Azioni |
| CANADA PENSION PLAN INVESTMENT BOARD | $261.530.030 | 676.260 | 0,32% | Azioni |
| Qube Research & Technologies Ltd | $247.577.198 | 640.181 | 0,30% | Azioni |
Insider aziendali 95 insider · 57 dirigenti · 37 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Gail Boudreaux | President and CEO | 17 Luglio 2026 P | 171.976 | 2 | 0 | $1.002.230 |
| Brian T Griffin | EVP & CEO, IngenioRx | 03 Maggio 2018 M | 15.863 | 0 | 0 | $0 |
| Angela F Braly | Chair, President & CEO | 01 Marzo 2012 A | 476.503 | 0 | 0 | $0 |
| Brian A Sassi | President & CEO Cons, EVP | 07 Giugno 2011 S | 60.825 | 0 | 0 | $0 |
| Dijuana K Lewis | Pres & CEO CHS and EVP | 20 Maggio 2010 M | 44.107 | 0 | 0 | $0 |
| Mark L Boxer | Pres & CEO of OT&GS and EVP | 04 Aprile 2008 F | 42.143 | 0 | 0 | $0 |
| Joan E Herman | President & CEO Cons and EVP | 07 Dicembre 2007 S | 30.369 | 0 | 0 | $0 |
| Mark Kaye | EVP & CFO | 02 Marzo 2026 A | 32.037 | 0 | 0 | $0 |
| John E Gallina | EVP & Chief Financial Officer | 01 Marzo 2023 A | 63.725 | 0 | 0 | $0 |
| Wayne S Deveydt | EVP & Chief Financial Officer | 03 Marzo 2016 F | 57.957 | 0 | 0 | $0 |
| David C Colby | Vice Chairman, CFO & EVP | 04 Aprile 2007 F | 343.071 | 0 | 0 | $0 |
| Thomas R Byrd | President, Anthem Specialty | 26 Novembre 2004 A | 26.580 | 0 | 0 | $0 |
| Michael D Houk | President, National Accounts | 04 Novembre 2004 M | 18.843 | 0 | 0 | $0 |
| John M Murphy | President, Specialty Business | 17 Maggio 2004 A | 20.806 | 0 | 0 | $0 |
| Caroline S Matthews | Chief Operating Officer | 01 Dicembre 2004 A | 40.471 | 0 | 0 | $0 |
| Erin M Wessling | EVP & Chief Legal Officer | 03 Settembre 2026 F | 7.230 | 0 | 0 | $0 |
| Ryan R Craig | EVP & Chief HR Officer | 02 Settembre 2026 F | 6.530 | 0 | 0 | $0 |
| Ronald W Penczek | CAO & Controller | 12 Giugno 2026 S | 3.740 | 0 | 2 | $-765.958 |
| Charles Morgan Kendrick JR | EVP & President, Commercial | 06 Marzo 2026 S | 11.791 | 0 | 1 | $-910.604 |
| Peter D Haytaian | EVP & Pres Carelon & CarelonRx | 03 Marzo 2026 F | 27.222 | 0 | 0 | $0 |
| Felicia F Norwood | EVP &Chief Health Benefits Ofr | 02 Marzo 2026 A | 38.838 | 0 | 0 | $0 |
| Ratnakar Lavu | EVP & Chief Digital Info Ofr | 02 Marzo 2026 A | 16.149 | 0 | 0 | $0 |
| Blair Williams Todt | EVP, CLO & CAO | 03 Gennaio 2025 F | 15.631 | 0 | 0 | $0 |
| Gloria M Mccarthy | EVP & Chief Administrative Off | 24 Marzo 2023 S | 51.435 | 0 | 0 | $0 |
| Leah Stark | EVP & CHRO | 30 Dicembre 2021 F | 12.403 | 0 | 0 | $0 |
| Jeffrey D. Alter | EVP, IngenioRx & Anthem Health | 01 Ottobre 2021 F | 5.107 | 0 | 0 | $0 |
| Patel Prakash R | EVP & President, DBG | 04 Settembre 2021 F | 17.230 | 0 | 0 | $0 |
| Thomas C Zielinski | EVP & General Counsel | 03 Novembre 2020 M | 17.910 | 0 | 0 | $0 |
| Craig E Samitt | EVP & President, DBG | 26 Luglio 2018 M | 17.274 | 0 | 0 | $0 |
| Joseph Swedish | Executive Chairman | 05 Marzo 2018 S | 61.419 | 0 | 0 | $0 |
| Jacquelyn H Wolf | EVP & Chief HR Officer | 01 Marzo 2018 A | 3.105 | 0 | 0 | $0 |
| Jose D. Tomas | EVP & Chief HR Officer | 03 Marzo 2017 F | 23.927 | 0 | 0 | $0 |
| Samuel R Nussbaum MD | EVP & Chief Medical Officer | 19 Maggio 2015 M | 110.973 | 0 | 0 | $0 |
| Martin B Silverstein | EVP & Chief Strategy Officer | 01 Maggio 2015 F | 23.249 | 0 | 0 | $0 |
| Kenneth R Goulet | EVP, Commercial & Specialty | 02 Marzo 2015 A | 84.281 | 0 | 0 | $0 |
| Richard C Zoretic | EVP, Gov Business Division | 03 Marzo 2014 A | 53.572 | 0 | 0 | $0 |
| John Cannon | EVP, GC & Chief PAO | 13 Dicembre 2013 S | 99.331 | 0 | 0 | $0 |
| Randal L Brown | EVP & Chief HR Officer | 04 Settembre 2013 M | 30.332 | 0 | 0 | $0 |
| Lori A Beer | EVP, Specialty Businesses & IT | 30 Maggio 2013 M | 113.955 | 0 | 0 | $0 |
| Harlan A Levine | EVP, CHS | 31 Agosto 2012 S | 25.244 | 0 | 0 | $0 |
| Venkata R Madabhushi | EVP Sr Bus & Chf Transfrmn Off | 02 Aprile 2012 A | 45.237 | 0 | 0 | $0 |
| Miller Martin | SVP & Chief Accounting Officer | 01 Marzo 2011 A | 29.329 | 0 | 0 | $0 |
| Fluegel M Bradley | EVP, Chief Strategy Officer | 05 Novembre 2010 M | 52.634 | 0 | 0 | $0 |
| Cynthia S Miller | EVP & Chief Actuary | 01 Marzo 2010 A | 60.757 | 0 | 0 | $0 |
| Randall J Lewis | EVP & Chief Compliance Officer | 07 Agosto 2009 M | 13.658 | 0 | 0 | $0 |
| Jamie S Miller | SVP & Chief Accounting Officer | 03 Marzo 2008 A | 25.710 | 0 | 0 | $0 |
| Alice F Rosenblatt | EVP and Chief Actuary | 22 Gennaio 2008 S | 39.265 | 0 | 0 | $0 |
| John S Watts JR | EVP | 07 Dicembre 2007 S | 108.311 | 0 | 0 | $0 |
| Marjorie W Dorr | EVP | 22 Maggio 2007 M | 38.951 | 0 | 0 | $0 |
| Michael A Stocker | EVP | 23 Ottobre 2006 M | 42.186 | 0 | 0 | $0 |
| Keith R Faller | EVP | 12 Settembre 2006 M | 83.290 | 0 | 0 | $0 |
| David S Helwig | EVP | 18 Agosto 2006 M | 55.055 | 0 | 0 | $0 |
| Thomas G Snead JR | EVP | 31 Gennaio 2006 M | 0 | 0 | 0 | $0 |
| Ronald J Ponder | EVP | 18 Novembre 2005 M | 55.313 | 0 | 0 | $0 |
| David R Frick | EVP | 12 Maggio 2005 S | 58.241 | 0 | 0 | $0 |
| Michael L Smith | EVP | 18 Febbraio 2005 S | 98.810 | 0 | 0 | $0 |
| Jane E Niederberger | Senior Vice President and Chie | 17 Maggio 2004 A | 28.648 | 0 | 0 | $0 |
| Ramiro G Peru | Direttore | 17 Luglio 2026 P | 10.908 | 1 | 0 | $366.050 |
| Robert L Dixon JR | Direttore | 11 Giugno 2026 S | 10.734 | 0 | 1 | $-60.667 |
| Bahija Jallal | Direttore | 13 Maggio 2026 A | 5.351 | 0 | 0 | $0 |
| Antonio F Neri | Direttore | 13 Maggio 2026 A | 5.488 | 0 | 0 | $0 |
| Susan D. Devore | Direttore | 13 Maggio 2026 A | 4.065 | 0 | 0 | $0 |
| Amy Schulman | Direttore | 13 Maggio 2026 A | 781 | 0 | 1 | $-7.475 |
| Ryan M. Schneider | Direttore | 13 Maggio 2026 A | 7.163 | 0 | 0 | $0 |
| Deanna D Strable-Soethout | Direttore | 13 Maggio 2026 A | 2.209 | 0 | 0 | $0 |
| Steven H Collis | Direttore | 13 Maggio 2026 A | 4.202 | 1 | 0 | $869.520 |
| Lewis Hay III | Direttore | 13 Maggio 2026 A | 12.070 | 0 | 0 | $0 |
| Kerry R Clark | Direttore | 14 Maggio 2025 A | 9.640 | 0 | 0 | $0 |
| Elizebeth E Tallett | Direttore | 15 Maggio 2024 A | 10.291 | 0 | 0 | $0 |
| Julie A Hill | Direttore | 20 Maggio 2021 S | 31.213 | 0 | 0 | $0 |
| George A Schaefer JR | Direttore | 16 Maggio 2018 A | 38.864 | 0 | 0 | $0 |
| William J Ryan | Direttore | 28 Luglio 2016 S | 27.149 | 0 | 0 | $0 |
| John H Short | Direttore | 14 Maggio 2014 A | 2.981 | 0 | 0 | $0 |
| Warren Y Jobe | Direttore | 13 Marzo 2014 G | 26.525 | 0 | 0 | $0 |
| Lenox D Baker JR MD | Direttore | 08 Marzo 2013 M | 71.155 | 0 | 0 | $0 |
| Susan B Bayh | Direttore | 21 Maggio 2012 S | 0 | 0 | 0 | $0 |
| Sheila P Burke | Direttore | 16 Maggio 2012 A | 16.200 | 0 | 0 | $0 |
| Jackie M Ward | Direttore | 16 Maggio 2012 A | 23.806 | 0 | 0 | $0 |
| William H T Bush | Direttore | 17 Maggio 2011 M | 28.383 | 0 | 0 | $0 |
| William G Mays | Direttore | 17 Maggio 2011 A | 19.878 | 0 | 0 | $0 |
| Donald W Riegle JR | Direttore | 16 Maggio 2011 M | 3.894 | 0 | 0 | $0 |
| Jane G Pisano | Direttore | 10 Maggio 2010 M | 3.692 | 0 | 0 | $0 |
| Victor S Liss | Direttore | 10 Maggio 2010 M | 4.658 | 0 | 0 | $0 |
| Larry C Glasscock | Direttore | 25 Febbraio 2010 M | 3.352 | 0 | 0 | $0 |
| John Zuccotti | Direttore | 20 Maggio 2009 A | · | 0 | 0 | $0 |
| Ben L Lytle | Direttore | 10 Maggio 2005 A | 2.128 | 0 | 0 | $0 |
| Leonard D Schaeffer | Direttore | 10 Maggio 2005 A | 1.041.024 | 0 | 0 | $0 |
| Allan B Hubbard | Direttore | 14 Febbraio 2005 M | 0 | 0 | 0 | $0 |
| John Sherman JR | Direttore | 01 Dicembre 2004 M | 4.164 | 0 | 0 | $0 |
| James W Mcdowell JR | Direttore | 01 Ottobre 2004 A | 1.271 | 0 | 0 | $0 |
| Dennis J Sullivan JR | Direttore | 26 Luglio 2004 M | 2.837 | 0 | 0 | $0 |
| Leeba Lessin | · | 01 Marzo 2013 A | 15.451 | 0 | 0 | $0 |
| Rebecca A Kapustay | · | 01 Aprile 2005 M | 34.557 | 0 | 0 | $0 |
| SANDERS ELIZABETH A | · | 03 Marzo 2005 S | 35.604 | 0 | 0 | $0 |
| William B Hart | · | 01 Ottobre 2004 A | 439 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 165 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IHF · iShares Trust | 7,53% | 237.106 SH | 11 Settembre 2026 | Giornaliero |
| CVGD · Elevation Series Trust | 3,56% | 13.113 NS | 31 Luglio 2026 | N-PORT |
| FDIV · EA Series Trust | 1,95% | 3.050 NS | 31 Luglio 2026 | N-PORT |
| BKDV · BNY Mellon ETF Trust II | 1,65% | 80.785 NS | 31 Luglio 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,64% | 45.819 NS | 31 Luglio 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,59% | 36.229 SH | 02 Ottobre 2026 | Giornaliero |
| RPV · Invesco Exchange-Traded Fund Trust | 1,55% | 67.848 SH | 02 Ottobre 2026 | Giornaliero |
| PWV · Invesco Exchange-Traded Fund Trust | 1,46% | 69.517 SH | 02 Ottobre 2026 | Giornaliero |
| IYH · iShares Trust | 1,46% | 127.077 SH | 11 Settembre 2026 | Giornaliero |
| SRHQ · Elevation Series Trust | 1,41% | 7.981 NS | 31 Luglio 2026 | N-PORT |
| IMCV · iShares Trust | 1,22% | 34.046 SH | 11 Settembre 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 1,22% | 645.908 SH | 19 Agosto 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 1,19% | 104.494 NS | 31 Luglio 2026 | N-PORT |
| VMAX · Lattice Strategies Trust | 1,18% | 1.543 NS | 31 Luglio 2026 | N-PORT |
| IXJ · iShares Trust | 1,15% | 114.143 SH | 11 Settembre 2026 | Giornaliero |
| REVS · Columbia ETF Trust I | 1,12% | 9.954 NS | 31 Luglio 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,99% | 252.365 SH | 02 Ottobre 2026 | Giornaliero |
| CURE · Direxion Shares ETF Trust | 0,94% | 4.273 NS | 31 Luglio 2026 | N-PORT |
| NUDV · Nushares ETF Trust | 0,92% | 1.235 NS | 31 Luglio 2026 | N-PORT |
| SYLD · Cambria ETF Trust | 0,92% | 24.249 NS | 31 Luglio 2026 | N-PORT |
| ESMV · iShares Trust | 0,91% | 170 SH | 11 Settembre 2026 | Giornaliero |
| EQIN · Columbia ETF Trust I | 0,86% | 6.959 NS | 31 Luglio 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0,74% | 13.856 NS | 31 Luglio 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,73% | 15.896 SH | 19 Agosto 2026 | Giornaliero |
| RECS · Columbia ETF Trust I | 0,73% | 112.966 NS | 31 Luglio 2026 | N-PORT |
| VLUE · iShares Trust | 0,71% | 163.004 SH | 11 Settembre 2026 | Giornaliero |
| NULC · Nushares ETF Trust | 0,69% | 1.301 NS | 31 Luglio 2026 | N-PORT |
| FBCV · FIDELITY COVINGTON TRUST | 0,68% | 3.202 NS | 31 Luglio 2026 | N-PORT |
| FEUS · FlexShares Trust | 0,61% | 1.815 NS | 31 Luglio 2026 | N-PORT |
| IMCB · iShares Trust | 0,61% | 24.486 SH | 11 Settembre 2026 | Giornaliero |
| FDLO · FIDELITY COVINGTON TRUST | 0,60% | 22.637 NS | 31 Luglio 2026 | N-PORT |
| DIVB · iShares Trust | 0,54% | 26.159 SH | 11 Settembre 2026 | Giornaliero |
| IDRV · iShares Trust | 0,53% | 143.110 SH | 11 Settembre 2026 | Giornaliero |
| RDVI · First Trust Exchange-Traded Fund IV | 0,52% | 50.065 NS | 31 Luglio 2026 | N-PORT |
| XOEF · iShares Trust | 0,51% | 273 SH | 11 Settembre 2026 | Giornaliero |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,50% | 12.654 SH | 02 Ottobre 2026 | Giornaliero |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,49% | 18.161 NS | 31 Luglio 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,47% | 13.779.000 | 02 Ottobre 2026 | Giornaliero |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,45% | 16.207.990 | 02 Ottobre 2026 | Giornaliero |
| SUSA · iShares Trust | 0,45% | 43.466 SH | 11 Settembre 2026 | Giornaliero |
| ACWV · iShares, Inc. | 0,44% | 35.074 SH | 11 Settembre 2026 | Giornaliero |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,42% | 2.019 NS | 31 Luglio 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,42% | 106.873 SH | 02 Ottobre 2026 | Giornaliero |
| PALC · Pacer Funds Trust | 0,42% | 2.320 NS | 31 Luglio 2026 | N-PORT |
| EVUS · iShares Trust | 0,40% | 3.683 SH | 11 Settembre 2026 | Giornaliero |
| MGV · VANGUARD WORLD FUND | 0,39% | 133.635 SH | 19 Agosto 2026 | Giornaliero |
| DFUV · Dimensional ETF Trust | 0,38% | 154.644 NS | 31 Luglio 2026 | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,38% | 515.000 | 02 Ottobre 2026 | Giornaliero |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,37% | 8.210 NS | 31 Luglio 2026 | N-PORT |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,37% | 16.818.000 | 02 Ottobre 2026 | Giornaliero |
| USXF · iShares Trust | 0,36% | 12.883 SH | 11 Settembre 2026 | Giornaliero |
| DFLV · Dimensional ETF Trust | 0,36% | 65.144 NS | 31 Luglio 2026 | N-PORT |
| VIG · VANGUARD SPECIALIZED FUNDS | 0,36% | 1.200.113 SH | 19 Agosto 2026 | Giornaliero |
| FHEQ · Fidelity Greenwood Street Trust | 0,35% | 8.603 NS | 31 Luglio 2026 | N-PORT |
| VYM · VANGUARD WHITEHALL FUNDS | 0,34% | 847.792 SH | 19 Agosto 2026 | Giornaliero |
| CVY · Invesco Exchange-Traded Fund Trust | 0,34% | 1.030 SH | 02 Ottobre 2026 | Giornaliero |
| IWX · iShares Trust | 0,34% | 31.304 SH | 11 Settembre 2026 | Giornaliero |
| USMV · iShares Trust | 0,32% | 181.462 SH | 11 Settembre 2026 | Giornaliero |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,31% | 9.525.000 | 02 Ottobre 2026 | Giornaliero |
| DGRO · iShares Trust | 0,31% | 320.084 SH | 11 Settembre 2026 | Giornaliero |
| VTV · VANGUARD INDEX FUNDS | 0,31% | 2.021.174 SH | 19 Agosto 2026 | Giornaliero |
| PFM · Invesco Exchange-Traded Fund Trust | 0,31% | 6.186 SH | 02 Ottobre 2026 | Giornaliero |
| IVE · iShares Trust | 0,30% | 360.968 SH | 11 Settembre 2026 | Giornaliero |
| ACIO · ETF Series Solutions | 0,29% | 18.049 NS | 31 Luglio 2026 | N-PORT |
| IUSV · iShares Trust | 0,29% | 189.556 SH | 11 Settembre 2026 | Giornaliero |
| ADME · ETF Series Solutions | 0,28% | 2.222 NS | 31 Luglio 2026 | N-PORT |
| HDUS · Lattice Strategies Trust | 0,28% | 1.531 NS | 31 Luglio 2026 | N-PORT |
| ESG · FlexShares Trust | 0,28% | 990 NS | 31 Luglio 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,28% | 48.913 SH | 19 Agosto 2026 | Giornaliero |
| SUSL · iShares Trust | 0,26% | 7.654 SH | 11 Settembre 2026 | Giornaliero |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,26% | 10.930 NS | 31 Luglio 2026 | N-PORT |
| DSI · iShares Trust | 0,26% | 33.146 SH | 11 Settembre 2026 | Giornaliero |
| ILCV · iShares Trust | 0,25% | 8.135 SH | 11 Settembre 2026 | Giornaliero |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,24% | 1.096 NS | 31 Luglio 2026 | N-PORT |
| IWD · iShares Trust | 0,24% | 482.434 SH | 11 Settembre 2026 | Giornaliero |
| IQSU · New York Life Investments ETF Trust | 0,24% | 2.111 NS | 31 Luglio 2026 | N-PORT |
| FBUF · Fidelity Greenwood Street Trust | 0,24% | 152 NS | 31 Luglio 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 2.806 NS | 31 Luglio 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,23% | 128.096 SH | 19 Agosto 2026 | Giornaliero |
| ESGG · FlexShares Trust | 0,21% | 627 NS | 31 Luglio 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,21% | 9.792 SH | 11 Settembre 2026 | Giornaliero |
| FYEE · Fidelity Greenwood Street Trust | 0,21% | 1.194 NS | 31 Luglio 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,20% | 6 NS | 31 Luglio 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 492.177 SH | 02 Ottobre 2026 | Giornaliero |
| ESGU · iShares Trust | 0,19% | 83.443 SH | 11 Settembre 2026 | Giornaliero |
| SIZE · iShares Trust | 0,19% | 1.938 SH | 11 Settembre 2026 | Giornaliero |
| USCL · iShares Trust | 0,17% | 11.477 SH | 11 Settembre 2026 | Giornaliero |
| TOPC · iShares Trust | 0,17% | 133 SH | 11 Settembre 2026 | Giornaliero |
| DFSU · Dimensional ETF Trust | 0,16% | 9.705 NS | 31 Luglio 2026 | N-PORT |
| IWL · iShares Trust | 0,16% | 8.413 SH | 11 Settembre 2026 | Giornaliero |
| XVV · iShares Trust | 0,15% | 2.493 SH | 11 Settembre 2026 | Giornaliero |
| MGC · VANGUARD WORLD FUND | 0,15% | 42.364 SH | 19 Agosto 2026 | Giornaliero |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,15% | 6.353 SH | 02 Ottobre 2026 | Giornaliero |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,14% | 17.682 SH | 02 Ottobre 2026 | Giornaliero |
| ESGV · VANGUARD WORLD FUND | 0,14% | 47.980 SH | 19 Agosto 2026 | Giornaliero |
| IVV · iShares Trust | 0,14% | 2.737.349 SH | 11 Settembre 2026 | Giornaliero |
| ACVF · ETF Opportunities Trust | 0,14% | 548 NS | 31 Luglio 2026 | N-PORT |
| ILCB · iShares Trust | 0,13% | 4.087 SH | 11 Settembre 2026 | Giornaliero |
| BKLC · BNY Mellon ETF Trust | 0,13% | 18.995 NS | 31 Luglio 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,13% | 5.589.584 SH | 19 Agosto 2026 | Giornaliero |
| VV · VANGUARD INDEX FUNDS | 0,13% | 248.024 SH | 19 Agosto 2026 | Giornaliero |
| IWB · iShares Trust | 0,13% | 150.486 SH | 11 Settembre 2026 | Giornaliero |
| IYY · iShares Trust | 0,13% | 9.294 SH | 11 Settembre 2026 | Giornaliero |
| PBP · Invesco Exchange-Traded Fund Trust | 0,13% | 1.291 SH | 02 Ottobre 2026 | Giornaliero |
| PTLC · Pacer Funds Trust | 0,13% | 11.007 NS | 31 Luglio 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,13% | 37.605 SH | 02 Ottobre 2026 | Giornaliero |
| IWV · iShares Trust | 0,12% | 59.652 SH | 11 Settembre 2026 | Giornaliero |
| ITOT · iShares Trust | 0,12% | 282.740 SH | 11 Settembre 2026 | Giornaliero |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 28.858 NS | 31 Luglio 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,12% | 3.538 NS | 31 Luglio 2026 | N-PORT |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,12% | 35.020 SH | 19 Agosto 2026 | Giornaliero |
| TOV · EA Series Trust | 0,12% | 873 NS | 31 Luglio 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,12% | 65.434 NS | 31 Luglio 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,12% | 1.719 NS | 31 Luglio 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,12% | 820 NS | 31 Luglio 2026 | N-PORT |
| VOXP · Advisors Series Trust | 0,12% | 18 NS | 31 Luglio 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,12% | 5.228 NS | 31 Luglio 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,11% | 6.834.097 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,11% | 17.880 SH | 19 Agosto 2026 | Giornaliero |
| TOK · iShares Trust | 0,11% | 620 SH | 11 Settembre 2026 | Giornaliero |
| DFAC · Dimensional ETF Trust | 0,11% | 134.751 NS | 31 Luglio 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,11% | 171 SH | 02 Ottobre 2026 | Giornaliero |
| TILT · FlexShares Trust | 0,10% | 6.004 NS | 31 Luglio 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0,10% | 1.508 NS | 31 Luglio 2026 | N-PORT |
| URTH · iShares, Inc. | 0,10% | 19.735 SH | 11 Settembre 2026 | Giornaliero |
| DCOR · Dimensional ETF Trust | 0,10% | 8.835 NS | 31 Luglio 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,10% | 31.680 NS | 31 Luglio 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0,09% | 16.978 NS | 31 Luglio 2026 | N-PORT |
| GLOF · iShares Trust | 0,09% | 455 SH | 11 Settembre 2026 | Giornaliero |
| LGDX · Tidal Trust III | 0,09% | 342 NS | 31 Luglio 2026 | N-PORT |
| ACWI · iShares Trust | 0,09% | 69.481 SH | 11 Settembre 2026 | Giornaliero |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 1.815 SH | 02 Ottobre 2026 | Giornaliero |
| CRBN · iShares Trust | 0,08% | 2.188 SH | 11 Settembre 2026 | Giornaliero |
| NEAR · iShares U.S. ETF Trust | 0,08% | 3.886.000 SH | 11 Settembre 2026 | Giornaliero |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,07% | 290.778 SH | 19 Agosto 2026 | Giornaliero |
| PICK · iShares, Inc. | 0,06% | 266.862 SH | 11 Settembre 2026 | Giornaliero |
| DFVX · Dimensional ETF Trust | 0,05% | 720 NS | 31 Luglio 2026 | N-PORT |
| LRGF · iShares Trust | 0,03% | 2.746 SH | 11 Settembre 2026 | Giornaliero |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 571.538 SH | 19 Agosto 2026 | Giornaliero |
| SCZ · iShares Trust | 0,03% | 625.241 SH | 11 Settembre 2026 | Giornaliero |
| PEVC · Pacer Funds Trust | 0,02% | 1 NS | 31 Luglio 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0,01% | 13.133 SH | 11 Settembre 2026 | Giornaliero |
| IPAC · iShares Trust | 0,01% | 52.224 SH | 11 Settembre 2026 | Giornaliero |
| VPL · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 158.652 SH | 19 Agosto 2026 | Giornaliero |
| WSML · iShares Trust | 0,01% | 9.378 SH | 11 Settembre 2026 | Giornaliero |
| IEFA · iShares Trust | 0,00% | 1.291.652 SH | 11 Settembre 2026 | Giornaliero |
| IDEV · iShares Trust | 0,00% | 211.325 SH | 11 Settembre 2026 | Giornaliero |
| IXUS · iShares Trust | 0,00% | 168.378 SH | 11 Settembre 2026 | Giornaliero |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 2.181.735 SH | 19 Agosto 2026 | Giornaliero |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,00% | 1.468.301 SH | 19 Agosto 2026 | Giornaliero |
| VSGX · VANGUARD WORLD FUND | 0,00% | 30.111 SH | 19 Agosto 2026 | Giornaliero |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VSDB · VANGUARD MALVERN FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Luglio 2026 | Giornaliero |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Luglio 2026 | Giornaliero |
| VCEB · VANGUARD WORLD FUND | · | · | 30 Luglio 2026 | Giornaliero |
ELV Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
Target Price a 12 Mesi
21 analisti · 2026-10-01Target medio $451.38 +14,1%
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
Ultime notizie Notizie recenti che menzionano questa società
Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento
Nessun segnale aperto al momento — nessuna scheda è compilata, e questo è onesto.
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.